Drug abuse and psychiatric comorbidity

Current Opinion in Psychiatry

Volumn 12, Issue 3, 1999, Pages 291-295

  Lowe, Alison ^a  

^a ST ANN S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COMORBIDITY; DRUG ABUSE; HEALTH CARE QUALITY; HUMAN; MENTAL DISEASE; SCREENING; SHORT SURVEY;

EID: 0032798838     PISSN: 09517367     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001504-199905000-00006     Document Type: Short Survey

References (54)

1. 1 Johnson S. Dual Diagnosis of severe mental illness and substance misuse: a case for specialist services? Br J Psychiatry 1997; 171:205-208.
2. 2 Weaver T, Rentin A, Stimson G, Tyrer P. Editorial: severe mental illness and substance misuse. BMJ 1999; 318:137-138.
3. 3 Mueser KT, Drake RE, Wallach MA. Dual diagnosis: a review of ethiological theories. Addictive Behav 1998; 23:7217-7234. An excellent review of theories and the current state of evidence supporting them.
4. 4 Carey KB, Correia CJ. Severe mental illness and addictions: assessment considerations. Addictive Behav 1998; 23:735-748. This is an excellent overview of considerations about assessment and treatment planning issues.
5. 5 Buckley PF. Substance abuse in schizophrenia. A review. J Clin Psychiatry 1998; 59:26-30.
6. 6 Markou A, Koste n TR, Koob GF. Neurobiological similarities in depression and drug dependence: A self-medication hypothesis. Neuropsychopharmacology 1998; 18:135-174.
7. 7 Regier DA, Rae DS, Narrow WE, Kaeiber CT, Schatzberg AF. Prevalence of anxiety disorders and their comorbidity with mood and addictive disorders. Br J Psychiatry 1998; 173:34:24-28.
8. 8 Farrrell M, Howes S, Taylor C, Lewis G, Jenkins R, Bebbington P, et al. Substance misuse and psychiatric comorbidity: an overview of the OPCS National Psychiatric Morbidity Survey. Addictive Behav 1998; 23:909-918.
9. 9 Boutros NN, Bowers MB, Quinlan D. Chronological association between increases in drug abuse and psychosis in Connecticut State hospitals. J Neuropsychiatry Clin Neurosci 1998; 10: 48-54.
10. 10 Gossop M, Marsden J, Stewart D. NTORS at one year: The National Treatment Outcome Research Study. London: Department of Health.
11. 11 Feigelman W, Wallish LS, Lesieur HR. Problem gamblers, problem substance users and dual-problem individuals: An epidemiological study: Am J Public Health 1988; 3:467-470.
12. 12 Hughes JR, Howard TS. Nicotine and caffeine use as confounds in psychiatric studies. Biol Psychiatry 1997; 42:1184-1185.
13. 13 Weiss RD, Najavis LM, Greenfield SF, Soto JA, Shaw SR, Wyner D. Validity of substance use self-reports in dually diagnosed outpatients. Am J Psychiatry 1998; 155:127-128.
14. 14 Rosenberg SD, Drake RE, Wolford GL, Mueser KT, Oxman TE, Vidaver RM et al. Dartmouth assessment of lifestyle instrument (DALI): a substance use disorder screen for people with severe mental illness. Am J Psychiatry 1998; 155:232-238. An important paper with a new assessment tool from the Dartmouth group is presented.
15. 15 Pani PP, Trogu E, Agus A, Gessa GL. Psychiatric severity and treatment response in a comprehensive methadone maintenance treatment program. Drug Alcohol Depend 1997; 48:119-126.
16. 16 Petrakis I, Carroll KM, Nich C, Gordon L, Kosten T, Rounsavllle B. Fluoxetine treatment of depressive disorders in methadone-maintained opioid addicts. Drug Alcohol Depend 1998; 50:221-226.
17. 17 Nunes EV, Quitkin FM, Donovan SJ, Dellyannides D, Ocepekwellkson K, Koenig T, et al. Imipramine treatment of opiate-dependent patients with depressive disorders. A placebo-controlled trial. Arch Gen Psychiatry 1998; 55:153-160.
18. 18 Bobo JK, Mclivain HE, Leedkelly A. Depression screening scores during residential drug treatment and risk of drug use after discharge. Psychiatr Serv 1998; 49:693-695.
19. 19 Tomasson K, Vaglum P. The 2-year course following detoxification treatment of substance abuse: the possible influence of psychiatric cormobidity. Eur Arch Psychiatry Clin Neurosci 1997; 247:320-327.
20. 20 Johnsson E, Fridell M. Suicide attempts in a cohort of drug abusers: a 5-year follow-up study. Acta Psychiatr Scand 1997; 96:362-366. The authors provide interesting data about attempted suicide in this cohort.
21. 21 Neeleman J, Farrell M; Suicide and substance misuse. Br J Psychiatry 1997; 171:303-304.
22. 21 Gerra G, Ferri M, Zaimovic A, Glucaslro G, Palladino M, Satori R, et al. GABAergic function in detoxified heroin addicts: relationships to anxiety disorders. Psychiatry Res 1998; 77:89-96.
23. 23 Permenger TV, Giner F, del Rio M, Mino A. Randomised trail of heroin maintenance programme for addicts who fail in conventional drug treatments. BMJ 1998; 317:13-18.
24. 24 Breslau N, Peterson EL, Schultz LR, Chilcoal HD, Andreski P. Major depression and stages of smoking - a longitudinal investigation. Arch Gen Psychiatry 1998; 55:161-166.
25. 25 Trosi A, Pasini A, Saracco M, Spalletta G. Psychiatric Symptoms in male cannabis users not using other illicit drugs. Addiction 1998; 93: 487-492.
26. 26 Tidey JW, Mehimadrona L, Higgins ST, Badger GJ. Psychiatric symptom severity in cocaine-dependent outpatients: demographics, drug use characteristics and treatment outcome. Drug Alcohol Depend 1998; 50:9-17.
27. 27 Najavits LM, Gastfriend DR, Barber JP, Relf S, Muenz LR, Blane J, et al. Cocaine dependence with and without PTSD among subjects in the National Institute on Drug Abuse Collaborative Cocaine Treatment Study. Am J Psychiatry 1998; 155:214-219.
28. 28 Brown RA, Monti PM, Myers MG, Martin RA, Rivinus T, Dubreuil ME, et al. Depression among cocaine abusers in treatment: relation to cocaine and alcohol use and treatment outcome. Am J Psychiatry 1998; 155: 220-225.
29. 29 Carrol KM, Nich C. Ball SA, Mccance E, Rounsavile BJ. Treatment of cocaine and alcohol dependence with psychotherapy and disulffram. Addiction 1998; 93:713-727.
30. 30 Levin FR, Evans SM, Mcdowell DM, Kleber HD. Methylphenidate treatment for cocaine abusers with adult attention-deficit/hyperactivity disorder: a pilot study. J Clin Psychiatry 1998; 59:300-305.
31. 31 Birch D, Ashton H, Kamail F. Alcohol, drinking, illicit drug use, and stress in junior house officers in north-east England. Lancet 1998; 352: 9130:785-786.
32. 32 Scott H, Johnson S, Menzes P, Thornicroft G, Marshall J, Bindman J, et al. Substance misuse and risk of aggression and offending among the severely mentally ill. B J Psychiatry 1998; 172:345-350.
33. 33 Swartz MS, Swanson JW, Hiday VA, Borum R, Wagner HR, Burns BJ. Violence and severe mental illness: the effects of substance abuse and nonadherance to medication. Am J Psychiatry 1998; 155: 226-231.
34. 34 Kirchner JE, Owen RR, Nordquist C, Fischer EP. Diagnosis and management of substance use disorders among inpatients with schizophrenia. Psychiatr Serv 1998; 49:82-85. Higlights diagnositc uncertainies and lack of onward referral.
35. 35 Shaner A, Roberts LJ, Eckman TA, Racenstein JM, Tucker DE, Tsuang JW, et al. Sources of diagnostic uncertainty for chronically psychotic cocaine abusers. Psychiatr Serv 1998; 49:684-690.
36. 36 Addington J, Duchak V. Reasons for substance use in schizophrenia. Acta Psychiatr Scand 1997; 96:329-333.
37. 37 Havassy E, Ams PG. Relationship of cocaine and other substance dependence to well-being of high risk psychiatric patients. Psychiatr Serv 1998; 49:935-940.
38. 38 Conley RR, Kelly DL, Gala EA. Olanzapine response in treatment-refractory schizophrenic patients with a history of substance abuse. Schizophr Res 1998; 33:95-101. Highlights the need for biochemical validation of history.
39. 39 Claasssen CA, Gilfilan S, Orsulak P. Substance use among patients with a psychotic disorder in a psychiatric emergency room (vol 48, pg 353, 1997). Psychiatr Serv 1997; 48:1570.
40. 40 Lin CC, Bal YM, Hu PG, Yeh HS. Substance use disorders among inpatient with bipolar disorder and major depressive disorder in a general hospital. Gen Hosp Psychiatry 1998; 20:98-101.
41. 41 Woiss RD, Greeenfield SF, Najavits LM, Soto JA, Wyner D, Tohen M, et al. Medication compliance among patients with bipolar disorder and substance use disorder. J Clin Psychiatry 1998; 59:172-174.
42. 42 Ouimette PC, Brown PH, Najavitis LM. Course and treatment of patients with both substance use and posttraumatic stress disorders. Addict Behav 1998; 23:785-794.
43. 43 Stewart SH, Pihl OR, Conrod PJ, Dongier M. Functional associations among trauma, PTSD, and substance-related disorders. Addictive Behav 1998; 23:797-812.
44. 44 McFarlane AC. Epidemiological evidence about the relationship between PTSD and alcohol abuse: The nature of the association. Addictive Behav 1998; 23:813-825.
45. 45 Najavits LM, Weiss RD, Shaw SR, Muenz LR. 'Seeking safety'. Outcome of a new cognitive-behavioral psychotherapy for women with posttraumatic stress disorder and substance dependence. J Trauma Stress 1998; 11:437-56.
46. 46 Biederman J, Wilens TE, Mick E, Faraone SV, Spencer T. Does attention-deficit hyperactivity disorder impact the developmental course of drug and alcohol abuse and dependence? Biol Psychiatry 1998; 44:269-273.
47. 47 Miller-Johnson S, Lochman JE, Cole JD, Terry R, Hyman C. Cormorbidity of conduct and depressive problems at sixth grade: substance use outcomes across adolescence. J Abnorm Child Psychol 1998; 26:221-232.
48. 48 Alterman AI, McDermott PA, Caccloia JS, Rutherford MJ, Boardman CR, McKay R et al. A typology of antisocialilty in methadone patients. J Abnorm Psychol 1998; 107:221-232.
49. 49 Ball SA, Tennen H, Poling JC, Kranzler HR, Rounsaville BJ. Personality, temperament, and character dimensions and the DSM-IV personality disorder in substance abusers. J Abnorm Psychol 1997; 106:545-553.
50. 50 Vanhom DH.A, Frank AF, Substance-use situations and abstinence predictions in substance abusers with and without personality disorders. Am J Drug Alcohol Abuse 1998; 24:395-404.
51. 51 Cottler LB, Compton WM, Ridenour A, Abdallah AB, Gallagher T. Reliability of self reported antisocial personality disorder symptoms amongst substance abusers. Drug Alcohol Depend 1998; 49:189-199.
52. 52 Brooner RK, Kidorf M, King VL, Stoller K. Preliminary evidence of good treatment response in antisocial drug abusers. Drug Alcohol Depend 1998; 49: 249-260.
53. 53 Ridgely MS, Lambert D, Goodman A, Chichester CS, Ralph R. Interagency collaboration in services for people with co-occurring mental illness and substance use disorder. Psychiatr Serv 1997; 49:236-238.
54. 54 Dixon L, McNary S, Lehman AF. Remission of substance use disorder among psychiatric inpatient with mental illness. Am J Psychiatry 1998; 154:1610-1612.